ST-200 series

N/A

Report date: 2025/01/26 19:04:25
NME

Base Information

Drug NameST-200 series
Drug Alias NameNav1.7 sodium channel inhibitors (SiteOne Therapeutics)ST-2XX
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type IX alpha subunit blockers
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsPainPruritus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSiteone Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSiteone Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPainPruritus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A